Related Experiment Video
Updated: Nov 19, 2025

Murine Ileocolic Bowel Resection with Primary Anastomosis
Published on: October 29, 2014
Medical and Endoscopic Management of Crohn Disease
Parakkal Deepak1, Daniel R Ludwig2, Jeff L Fidler3
1Washington University Inflammatory Bowel Diseases Center, Division of Gastroenterology, Washington University in Saint Louis School of Medicine, St. Louis, MO.
Insights
This review clarifies Crohn disease risk stratification and treatment guidelines from major international organizations. It highlights imaging roles and therapeutic targets for better patient outcomes.
Area of Science:
- Gastroenterology and Inflammatory Bowel Diseases
- Medical Imaging in Crohn Disease
- Therapeutic Strategies for Crohn Disease
Background:
- Current Crohn disease management involves risk stratification into low-risk (mild-moderate) and high-risk (moderate-severe) categories.
- Established guidelines from international organizations guide treatment decisions for different risk profiles.
Purpose of the Study:
- To review current Crohn disease classification and risk stratification approaches.
- To detail recommended treatment strategies based on international guidelines.
- To summarize the pipeline of novel Crohn disease therapies and explore imaging's role.
Main Methods:
- Review of current literature and guidelines from key inflammatory bowel disease organizations.
- Analysis of magnetic resonance enterography and pelvis imaging findings relevant to clinical teams.
- Exploration of endoscopic and radiological targets within a treat-to-target framework.
Main Results:
- Provides a Q&A format to understand Crohn disease risk stratification.
- Details guideline-recommended treatments for mild-moderate and moderate-severe Crohn disease.
- Summarizes emerging therapies and the communication of imaging findings in multidisciplinary care.
Conclusions:
- Accurate risk stratification is crucial for tailoring Crohn disease treatment.
- Multidisciplinary collaboration, informed by imaging, optimizes patient outcomes.
- A treat-to-target approach using endoscopic and radiological markers is essential for effective Crohn disease management.
Abstract:
In this review, through a series of questions and answers, we explore the current approach to classifying patients with Crohn disease into low-risk (mild-moderate) and high-risk (moderate-severe) categories with the recommended treatment approaches per guidelines from the International Organization for the Study of Inflammatory Bowel Diseases, American Gastroenterological Association, the American College of Gastroenterology, and the European Crohn's and Colitis Organization detailed here. The development pipeline of potential therapies is also summarized. We also review key information from magnetic resonance enterography and pelvis imaging studies that the abdominal radiologist can communicate to a multidisciplinary treatment team that includes gastroenterologists and colorectal surgeons, with a goal of achieving optimal patient outcomes. Lastly, endoscopic and radiological treatment targets in a treat-to-target approach in Crohn disease are explored.
Related Concept Videos
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Chronic Pancreatitis II: Collaborative Care
Assessment:

